VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Kongsberg Gruppen ASA vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Kongsberg Gruppen ASA
KOG · Euronext Oslo Bors
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Kongsberg Gruppen ASA's moat claims, evidence, and risks.
View KOG analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 81 / 100 for Kongsberg Gruppen ASA).
- Segment focus: Kongsberg Gruppen ASA has 4 segments (49.5% in Kongsberg Maritime); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Kongsberg Gruppen ASA has 9 moat types across 4 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Kongsberg Gruppen ASA
Kongsberg Maritime
Maritime technology & integrated ship systems (propulsion, automation, bridge, energy efficiency, service)
Global
Shipyards, shipowners, offshore operators, naval customers
OEM and systems integrator; aftermarket service provider
49.5%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Kongsberg Gruppen ASA strengths
Novo Nordisk A/S strengths
Segment mix
Kongsberg Gruppen ASA segments
Full profile >Kongsberg Maritime
Oligopoly
Kongsberg Defence & Aerospace
Oligopoly
Kongsberg Discovery
Competitive
Kongsberg Digital
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.